University Hospital Centre Zagreb
Zagreb, Croatia
7 recruiting
Showing 1–17 of 17 trials
Recruiting
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
All Tumor Types
European Organisation for Research and Treatment of Cancer - EORTC4,975 enrolled134 locationsNCT02834884
Recruiting
Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen444 enrolled107 locationsNCT06700343
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
Phase 3
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Ulcerative Colitis
Alfasigma S.p.A.80 enrolled51 locationsNCT06865417
Recruiting
Phase 4
Therapeutic Options for CRAB
Infections, BacterialSepsis Bacterial
Clinical Hospital Centre Zagreb108 enrolled1 locationNCT06440304
Recruiting
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)300 enrolled36 locationsNCT05700149
Recruiting
Not Applicable
Differences in Speed of Recovery From Anesthesia for Intraoral Surgery
Intraoral Tumor
Clinical Hospital Centre Zagreb42 enrolled1 locationNCT06275087
Recruiting
Phase 3
Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Acute Major Bleeding
Octapharma260 enrolled63 locationsNCT04867837
Recruiting
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Haemophilia A
Octapharma200 enrolled55 locationsNCT03695978
Recruiting
Phase 4
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Severe Hemophilia A
Octapharma28 enrolled18 locationsNCT05935358
Recruiting
Phase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
MyelofibrosisPrimary MyelofibrosisMF+2 more
Kartos Therapeutics, Inc.600 enrolled215 locationsNCT06479135
Recruiting
Not Applicable
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
Heart FailureAtrial FibrillationTachycardia-induced Cardiomyopathy
University Medical Centre Ljubljana82 enrolled10 locationsNCT05467163
Recruiting
Not Applicable
Haemophilia and Bone Loss - PHILEOS Study
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne480 enrolled23 locationsNCT04384341
Recruiting
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
Coronary Bypass Graft Occlusion
University Hospital, Basel, Switzerland480 enrolled3 locationsNCT04595630
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707
Recruiting
Not Applicable
Impact of Coronary Sinus Flow Reducer on Coronary Microcirculation and Myocardial Ischemia
Coronary Artery DiseaseAngina Pectoris
Clinical Hospital Centre Zagreb25 enrolled1 locationNCT06266065
Recruiting
H. Pylori Screen-and-treat Study in a Population of Young Adults
Gastric CancerH.Pylori InfectionH Pylori Eradication+1 more
University of Latvia6,800 enrolled7 locationsNCT06275204